Checkpoint Therapeutics Inc (CKPT)
3.75
+0.28
(+8.07%)
USD |
NASDAQ |
Nov 22, 16:00
3.72
-0.03
(-0.80%)
After-Hours: 20:00
Checkpoint Therapeutics Enterprise Value: 178.42M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 178.42M |
| November 21, 2024 | 164.75M |
| November 20, 2024 | 160.35M |
| November 19, 2024 | 160.35M |
| November 18, 2024 | 156.44M |
| November 15, 2024 | 162.79M |
| November 14, 2024 | 179.88M |
| November 13, 2024 | 172.07M |
| November 12, 2024 | 163.77M |
| November 11, 2024 | 151.07M |
| November 08, 2024 | 159.86M |
| November 07, 2024 | 153.75M |
| November 06, 2024 | 149.63M |
| November 05, 2024 | 146.42M |
| November 04, 2024 | 155.12M |
| November 01, 2024 | 156.04M |
| October 31, 2024 | 152.83M |
| October 30, 2024 | 161.08M |
| October 29, 2024 | 171.15M |
| October 28, 2024 | 163.82M |
| October 25, 2024 | 163.37M |
| October 24, 2024 | 152.83M |
| October 23, 2024 | 151.46M |
| October 22, 2024 | 140.01M |
| October 21, 2024 | 140.93M |
| Date | Value |
|---|---|
| October 18, 2024 | 133.14M |
| October 17, 2024 | 131.31M |
| October 16, 2024 | 124.44M |
| October 15, 2024 | 116.20M |
| October 14, 2024 | 111.39M |
| October 11, 2024 | 106.81M |
| October 10, 2024 | 103.83M |
| October 09, 2024 | 102.46M |
| October 08, 2024 | 103.83M |
| October 07, 2024 | 107.04M |
| October 04, 2024 | 96.96M |
| October 03, 2024 | 95.13M |
| October 02, 2024 | 97.88M |
| October 01, 2024 | 95.59M |
| September 30, 2024 | 97.88M |
| September 27, 2024 | 96.34M |
| September 26, 2024 | 95.44M |
| September 25, 2024 | 95.89M |
| September 24, 2024 | 94.99M |
| September 23, 2024 | 101.29M |
| September 20, 2024 | 103.54M |
| September 19, 2024 | 104.44M |
| September 18, 2024 | 105.79M |
| September 17, 2024 | 108.49M |
| September 16, 2024 | 100.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.03M
Minimum
Dec 08 2022
313.42M
Maximum
Nov 09 2021
98.18M
Average
81.93M
Median
Jan 22 2020
Enterprise Value Benchmarks
| Fortress Biotech Inc | 5.421M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.725M |
| Total Expenses (Quarterly) | 9.724M |
| EPS Diluted (Quarterly) | -0.23 |
| Earnings Yield | -49.07% |
| Normalized Earnings Yield | -44.59 |